Dr Mary McCormack is a consultant clinical oncologist at University College London Hospitals specialising in the non-surgical management of gynecological cancers (radiation/chemotherapy and biological therapy).
She is active in clinical research contributing to both national and international clinical trial efforts. Dr McCormack is the current chair of the international Cervical Cancer Research Network (CCRN) and an executive member of the Gynecologic Cancer Intergroup (GCIG). She is a current member of the International Gynecologic Cancer Society (IGCS) education committee and the ASCO international affairs committee (IAC).
She is particularly interested in cervical cancer treatment, radiation injury to bowel, fertility and cancer therapy in general and targeted agents in breast and gynaecological cancer. She is a major contributor to National and International clinical trials.
McCormack M; Radiotherapy and Pregnancy 2008 in Cancer and Reproductive Health edited by Kehoe et al
Olaitan A, McCormack M; Centralisation of services for the management of ovarian cancer: arguments for, British Journal Obstetrics and Gyunaecology 2007; 114: 1188-1190.
Yu CK, Chiu C, McCormak M, Olaitan A Delayed Diagnosis of Cervical Cancer in Young Women, Journal of Obstetrics and Gynaecology 2005: 25: 367-370.
McCormack M, Brown RSD, Payne HA, The principles of radiotherapy In the Scientific Basis of Urology, 2nd edition, Mundy AR ed, Oxford, ISIS Medical Media 2002.
Thomas H, McCormack M, Mucins as markers in breast cancer. Tumour marker update 19987; 107-9
McCormack M, Nias AHW, Smith E Chronic Anaemia, Hyperbaric Oxygen and tumour Radisensitivity, British Journal of Radiology 1990;;63:752-759
McCormack M Anaemia Hyperbaric Oxygen and The Radiotherapy of tumours, PhD thesis. University of London January 1989.